Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
36.61%
↑ 364% above average
Average (39q)
-13.84%
Historical baseline
Range
High:1045.00%
Low:-796.15%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 36.61% |
| Q2 2025 | 18.51% |
| Q1 2025 | -796.15% |
| Q4 2024 | 119.55% |
| Q3 2024 | 29.26% |
| Q2 2024 | -32.86% |
| Q1 2024 | 14.24% |
| Q4 2023 | 8.59% |
| Q3 2023 | 10.86% |
| Q2 2023 | 63.01% |
| Q1 2023 | -128.13% |
| Q4 2022 | -3.23% |
| Q3 2022 | 63.53% |
| Q2 2022 | -73.47% |
| Q1 2022 | 37.97% |
| Q4 2021 | -12.86% |
| Q3 2021 | -1.45% |
| Q2 2021 | -1.47% |
| Q1 2021 | -4.62% |
| Q4 2020 | -6.56% |
| Q3 2020 | -35.56% |
| Q2 2020 | 42.31% |
| Q1 2020 | -21.88% |
| Q4 2019 | -14.29% |
| Q3 2019 | 11.11% |
| Q2 2019 | 7.35% |
| Q1 2019 | -19.30% |
| Q4 2018 | -1.79% |
| Q3 2018 | -109.88% |
| Q2 2018 | 1045.00% |
| Q1 2018 | -185.71% |
| Q4 2017 | -153.85% |
| Q3 2017 | 200.00% |
| Q2 2017 | 7.14% |
| Q1 2017 | -50.00% |
| Q4 2016 | 12.50% |
| Q3 2016 | 11.11% |
| Q2 2016 | -157.14% |
| Q1 2016 | 65.00% |
| Q4 2015 | -547.25% |